Description

Ibrutinib is a highly effective targeted therapy used to treat various types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. As a Bruton’s tyrosine kinase (BTK) inhibitor, Ibrutinib works by blocking a protein that plays a crucial role in the growth and survival of cancer cells. This mechanism makes it a powerful treatment option for individuals battling certain cancers and immune-related disorders.

Ibrutinib targets and inhibits the BTK enzyme, which is essential for B-cell receptor signaling. B-cells are a type of white blood cell involved in immune function. In many blood cancers, such as CLL and MCL, the abnormal growth of these cells leads to tumor formation. By blocking BTK, Ibrutinib disrupts the signaling pathways that allow these cancerous cells to proliferate and spread, thus slowing or stopping tumor growth.

Altico Biotech is a leading API raw material supplier and pharmaceutical raw materials manufacturer, specializing in delivering high-quality ingredients for pharmaceuticals, cosmetics, and health food industries. As a trusted cosmetic ingredients supplier, they provide organic raw materials for cosmetics, including herbal extracts for cosmetics, ensuring natural and sustainable formulations. Their portfolio includes active pharmaceutical ingredients (API), nutraceutical raw materials, and bulk health food raw materials, catering to the growing demand for health and wellness products. Altico Biotech is your reliable partner for innovative and high-grade natural health food ingredients and nutraceutical raw materials supplier solutions.